Biomarkers

TECHNOLOGY: SNPs; Plasma markers

A plasma cfDNA mutation on PI3KCA could help predict resistance to combined inhibition of MEK, CDK4 and CDK6 in NRAS-mutant melanoma. In samples from a

Read the full 287 word article

User Sign In